Revolutionary Step in B2B: The First Verified & Trusted Pharma, Surgical & Medical Trade Automation Platform • Direct Factory Deals, Global Tenders & 7-Document Export Dossiers•Revolutionary Step in B2B: The First Verified & Trusted Pharma, Surgical & Medical Trade Automation Platform • Direct Factory Deals, Global Tenders & 7-Document Export Dossiers•
Product Recalls & Safety Alerts

Global Medical Product Alert: Mandatory DEG/EG Impurity Testing for Oral Liquid Pharmaceutical Excipients

Urgent pharmacovigilance alert reinforcing zero-tolerance screening for Diethylene Glycol (DEG) and Ethylene Glycol (EG) contamination in liquid excipients, including Glycerin (HS Code 2905.45), Propylene Glycol (HS Code 2905.32), and Sorbitol solutions.

  • Mandatory Release Testing: Every incoming drum of liquid excipient must undergo USP Gas Chromatography (GC-FID) limit testing confirming DEG and EG levels strictly ≤ 0.10% prior to compounding.
  • Supply Chain Traceability: Wholesalers are advised to reject unsealed drums or secondary-repackaged excipients lacking original manufacturer Certificates of Analysis (COA) and intact tamper-evident seals.

Official Source & Verification Reference

Issuing Authority: World Health Organization (WHO) Substandard & Falsified Products Alert • Reference: WHO-MPA-DEG-2026

Verify Official Source Document ↗
Global Medical Product Alert: Mandatory DEG/EG Impurity Testing for Oral Liquid Pharmaceutical Excipients | PharmaTrade Online Market Bulletin | PharmaTrade Online